Literature DB >> 18375044

Laparoscopic partial nephrectomy versus laparoscopic cryoablation for multiple ipsilateral renal tumors.

Yi-Chia Lin1, Burak Turna, Rodrigo Frota, Monish Aron, Georges-Pascal Haber, Kazumi Kamoi, Philippe Koenig, Inderbir S Gill.   

Abstract

BACKGROUND: Management of multiple ipsilateral renal tumors is a dilemma in clinical practice. The effects of minimally invasive nephron-sparing procedures in this group of patients have not been assessed.
OBJECTIVE: To evaluate the technical feasibility and outcomes of laparoscopic partial nephrectomy (LPN) and laparoscopic cryoablation (LCA) for multiple ipsilateral renal tumors. DESIGN, SETTING, AND PARTICIPANTS: Between September 1999 and December 2006, 27 patients were treated with minimally invasive nephron sparing surgery (LPN or LCA) for synchronous multiple ipsilateral renal tumors in a single operating session at our institution. Fourteen patients with 28 tumors underwent LPN, and 13 patients with 31 tumors underwent LCA as the sole treatment modality. INTERVENTION: Medical records were retrospectively reviewed and data were collected. MEASUREMENTS: Demographic, intraoperative, postoperative, and intermediate-term follow-up data were compared between the two groups. RESULTS AND LIMITATIONS: Patients in the LPN group had fewer tumors (2 vs. 2.4, p=0.04) and larger dominant tumor size (3.6 vs. 2.5 cm, p=0.005) in the affected kidney and lower preoperative serum creatinine levels (1 vs. 1.4 mg/dl, p=0.02). Compared to the LCA group, patients in the LPN group had greater estimated blood loss (200 vs. 125 ml, p=0.02) and longer hospital stays (90 vs. 52.3h, p=0.02). There were no open conversions, and no kidneys were lost. Complication rate, renal functional outcomes, and intermediate-term cancer-specific survival rates were similar between the two groups.
CONCLUSIONS: Both LPN and LCA are viable options for patients with multiple ipsilateral renal tumors in select patients. Renal functional outcomes, complication rates, and intermediate-term survival rates are comparable between the two groups in this small series.

Entities:  

Mesh:

Year:  2008        PMID: 18375044     DOI: 10.1016/j.eururo.2008.02.052

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

Review 1.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

Review 2.  Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.

Authors:  Christopher J Long; Daniel J Canter; Marc C Smaldone; Tianyu Li; Jay Simhan; Boris Rozenfeld; Ervin Teper; David Y T Chen; Richard E Greenberg; Rosalia Viterbo; Robert G Uzzo; Alexander Kutikov
Journal:  Can J Urol       Date:  2012-10       Impact factor: 1.344

3.  Initial experience with robot assisted partial nephrectomy for multiple renal masses.

Authors:  Ronald Boris; Miguel Proano; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

Review 4.  The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.

Authors:  Tobias Klatte; Nils Kroeger; Uwe Zimmermann; Martin Burchardt; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

5.  Comparison of Robot-Assisted Laparoscopic Partial Nephrectomy with Laparoscopic Cryoablation in the Treatment of Localised Renal Tumours: A Propensity Score-Matched Comparison of Long-Term Outcomes.

Authors:  Hui-Ying Liu; Chih Hsiung Kang; Hung-Jen Wang; Chien Hsu Chen; Hao Lun Luo; Yen-Ta Chen; Yuan-Tso Cheng; Po-Hui Chiang
Journal:  Diagnostics (Basel)       Date:  2021-04-23

6.  Staged, open, no-ischemia nephron-sparing surgery for bilateral-multiple kidney tumors in a patient with birt-hogg-dubé syndrome.

Authors:  Ahmet Tefekli; Ayşe Deniz Akkaya; Kamil Peker; Terman Gümüş; Metin Vural; Fatin Cezayirli; Ahmet Musaoglu; Tarık Esen
Journal:  Case Rep Med       Date:  2012-04-24

Review 7.  Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis.

Authors:  Wen Deng; Luyao Chen; Yibing Wang; Xiaoqiang Liu; Gongxian Wang; Weipeng Liu; Cheng Zhang; Xiaochen Zhou; Yu Li; Bin Fu
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

8.  Current status of ablative therapies for renal tumors.

Authors:  Adam C Mues; Jaime Landman
Journal:  Indian J Urol       Date:  2009 Oct-Dec

9.  Cryoablation for small renal masses.

Authors:  J L Dominguez-Escrig; K Sahadevan; P Johnson
Journal:  Adv Urol       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.